You are here

  • Home
  • Archive
  • Volume 9, Issue 11
  • Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: the CARACAS study

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: the CARACAS study

 

Online download statistics by month:

Online download statistics by month: November 2021 to March 2024

AbstractFullPdf
Nov 2021274278100
Dec 202126726896
Jan 202215115773
Feb 202210211051
Mar 20229210258
Apr 2022737541
May 202210711147
Jun 202212412738
Jul 2022818443
Aug 2022848728
Sep 2022929437
Oct 2022848937
Nov 2022666637
Dec 2022393921
Jan 2023424538
Feb 2023828431
Mar 2023474819
Apr 2023303117
May 2023323422
Jun 2023303017
Jul 2023494930
Aug 2023383922
Sep 2023292913
Oct 2023282821
Nov 2023454520
Dec 2023434318
Jan 2024495032
Feb 2024616135
Mar 2024444459
Total228523471101